Table of Contents
ISRN Minimally Invasive Surgery
Volume 2012, Article ID 942364, 10 pages
http://dx.doi.org/10.5402/2012/942364
Clinical Study

Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations

1Wayne State University, Detroit, MI 48201, USA
2Department of Radiology, Wayne State University, 22473 Milner Street, St. Clair Shores, MI 48081, USA
3Karmanos Cancer Center, Detroit, MI 48201, USA

Received 31 July 2012; Accepted 20 September 2012

Academic Editors: H. Baba, J. M. Regimbeau, and U. Witzsch

Copyright © 2012 Hyun J. Bang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Markowitz and M. M. Bertagnolli, “Molecular basis of colorectal cancer,” New England Journal of Medicine, vol. 361, no. 25, pp. 2404–2460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Howlader, A. M. Noone, M. Krapcho et al., Eds., SEER Cancer Statistics Review, 1975–2008, National Cancer Institute, Bethesda, MD, 2011, http://seer.cancer.gov/csr/1975_2008/.
  3. E. Van Cutsem, B. Nordlinger, R. Adam et al., “Towards a pan-European consensus on the treatment of patients with colorectal liver metastases,” European Journal of Cancer, vol. 42, no. 14, pp. 2212–2221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Yoo, R. I. Lopez-Soler, W. E. Longo, and C. H. Cha, “Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab,” Clinical Colorectal Cancer, vol. 6, no. 3, pp. 202–207, 2006. View at Google Scholar · View at Scopus
  5. E. Pihl, E. S. R. Hughes, and F. T. McDermott, “Lung recurrence after curative surgery for colorectal cancer,” Diseases of the Colon and Rectum, vol. 30, no. 6, pp. 417–419, 1987. View at Google Scholar · View at Scopus
  6. N. Starling, D. Tilden, J. White, and D. Cunningham, “Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment,” British Journal of Cancer, vol. 96, no. 2, pp. 206–212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Levy-Piedbois, I. Durand-Zaleski, H. Juhel, C. Schmitt, A. Bellanger, and P. Piedbois, “Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer,” Annals of Oncology, vol. 11, no. 2, pp. 157–161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. B. E. Hillner, D. Schrag, D. J. Sargent, C. S. Fuchs, and R. M. Goldberg, “Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma,” Cancer, vol. 104, no. 9, pp. 1871–1884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Tappenden, R. Jones, S. Paisley, and C. Carroll, “Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer,” Health Technology Assessment, vol. 11, no. 12, 2007. View at Google Scholar · View at Scopus
  10. S. Kopetz, G. J. Chang, M. J. Overman et al., “Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy,” Journal of Clinical Oncology, vol. 27, no. 22, pp. 3677–3683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Tomlinson, W. R. Jarnagin, R. P. DeMatteo et al., “Actual 10-year survival after resection of colorectal liver metastases defines cure,” Journal of Clinical Oncology, vol. 25, no. 29, pp. 4575–4580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. C. Cummings, J. D. Payes, and G. S. Cooper, “Survival after hepatic resection in metastatic colorectal cancer: a population-based study,” Cancer, vol. 109, no. 4, pp. 718–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. P. Khatri, N. J. Petrelli, and J. Belghiti, “Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?” Journal of Clinical Oncology, vol. 23, no. 33, pp. 8490–8499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. V. Pandharipande and G. S. Gazelle, “Comparative effectiveness research: what it means for radiology,” Radiology, vol. 253, no. 3, pp. 600–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Gillams and W. R. Lees, “Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation,” European Radiology, vol. 19, no. 5, pp. 1206–1213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. R. Knudsen, A. S. Kannerup, F. V. Mortensen, and D. T. Nielsen, “Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy,” Acta Radiologica, vol. 50, no. 7, pp. 716–721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Arellano, V. L. Flanders, S. I. Lee, P. R. Mueller, and D. A. Gervais, “Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients,” American Journal of Roentgenology, vol. 194, no. 6, pp. 1635–1638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Kerkar, A. M. Carlin, R. L. Sohn et al., “Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors,” Surgery, vol. 136, no. 4, pp. 770–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Wang, P. J. Littrup, Y. Duan, Y. Zhang, H. Feng, and Z. Nie, “Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures,” Radiology, vol. 235, no. 1, pp. 289–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Littrup, L. Freeman-Gibb, A. Andea et al., “Cryotherapy for breast fibroadenomas,” Radiology, vol. 234, no. 1, pp. 63–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. D. K. Bahn, F. Lee, R. Badalament, A. Kumar, J. Greski, and M. Chernick, “Targeted cryoablation of the prostate: 7-Year outcomes in the primary treatment of prostate cancer,” Urology, vol. 60, no. 2, pp. 3–11, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Littrup, A. Ahmed, H. D. Aoun et al., “CT-guided percutaneous cryotherapy of renal masses,” Journal of Vascular and Interventional Radiology, vol. 18, no. 3, pp. 383–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. A. Solomon, A. R. Munkarah, V. R. Vorugu et al., “Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases,” Gynecologic Oncology, vol. 111, no. 2, pp. 202–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Littrup, B. Jallad, P. Chandiwala-Mody, M. D'Agostini, B. A. Adam, and D. Bouwman, “Cryotherapy for breast cancer: a feasibility study without excision,” Journal of Vascular and Interventional Radiology, vol. 20, no. 10, pp. 1329–1341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Littrup, B. Jallad, V. Vorugu et al., “Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number,” Journal of Vascular and Interventional Radiology, vol. 20, no. 10, pp. 1343–1351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. W. Kam, P. J. Littrup, M. M. Walther, J. Hvizda, and B. J. Wood, “Thermal protection during percutaneous thermal ablation of renal cell carcinoma,” Journal of Vascular and Interventional Radiology, vol. 15, no. 7, pp. 753–758, 2004. View at Google Scholar · View at Scopus
  27. S. N. Goldberg, C. J. Grassi, J. F. Cardella et al., “Image-guided tumor ablation: standardization of terminology and reporting criteria,” Journal of Vascular and Interventional Radiology, vol. 16, no. 6, pp. 765–778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Lee and J. W. Wang, Statistical Methods for Survival Data Analysis, John Wiley & Sons, Hoboken, NJ, USA, 3rd edition, 2003.
  29. S. Folland, A. C. Goodman, and M. Stano, “Cost benefit analysis and other tools of economic evaluation.in,” in The Economics of Health and Health Care, pp. 74–96, Prentice Hall, Upper Saddle River, NJ, USA, 6th edition, 2010. View at Google Scholar
  30. T. D. Yan, J. King, A. Sjarif et al., “Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma,” Annals of Surgical Oncology, vol. 14, no. 5, pp. 1718–1726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Iannitti, D. E. Dupuy, W. W. Mayo-Smith, and B. Murphy, “Hepatic radiofrequency ablation,” Archives of Surgery, vol. 137, no. 4, pp. 422–427, 2002. View at Google Scholar · View at Scopus
  32. A. Anjomshoaa, S. Nasri, B. Humar et al., “Slow proliferation as a biological feature of colorectal cancer metastasis,” British Journal of Cancer, vol. 101, no. 5, pp. 822–828, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Milano, A. W. Katz, M. C. Schell, A. Philip, and P. Okunieff, “Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 5, pp. 1516–1522, 2008. View at Publisher · View at Google Scholar · View at Scopus